News

Uceris is a locally acting corticosteroid available in a novel, patented, oral tablet formulation, indicated for induction of remission of active ulcerative colitis. Santarus in collaboration with Cosmo

The project intends to determine the causes of Parkinson’s disease by mapping biological mutations of the Leucine-rich repeat kinase 2 (LRRK2) protein, which is believed to be the

IMO-3100 is a dual antagonist of Toll-like receptor (TLR) 7 and TLR9, which is indicated as a therapy for autoimmune and inflammatory diseases. In July 2011, the company

The facility aims to provide personalized medicine for different types of cancer, based on the latest genetic research findings and advances in synthetic organic chemistry. H3 Biomedicine intends

Ficlatuzumab is Aveo’s novel HGF inhibitory antibody that is currently in phase II clinical development to treat non-small cell lung cancer (NSCLC). Under the terms of the contract,

The solutions include cloud-based Veeva CRM and iRep. According to the company, the cloud solution will bring many business and operational benefits including faster deployment, better flexibility to

Ferrosan Consumer Health’s business provides dietary supplements and lifestyle product. Pfizer Consumer Healthcare president Paul Sturman said they have taken an important step by adding Ferrosan’s brands to

CK-2017357, a fast skeletal muscle troponin activator, increases skeletal muscle force in response to neuronal input, reducing the degree of muscle fatigue. The Phase II, double-blind placebo-controlled trial

Both the companies have finalized a one-year extension of the deal, under which Safecor Health will continue to provide unit-dose and bar-coded medication repackaging services to members and